All Seas Capital Backs Sereni in Buy-and-Build Healthcare Play

All Seas Capital, a Miami-based private equity firm specializing in lower middle-market investments, has announced a strategic partnership with Sereni, a Florida-based women's wellness platform, to accelerate growth through an aggressive buy-and-build strategy. The deal, announced March 4, 2026, positions Sereni as a consolidation vehicle in the fragmented women's healthcare services market, with plans to acquire complementary businesses and expand service offerings across multiple locations.

The transaction represents a significant bet on the continued consolidation of specialty healthcare services, a sector that has attracted substantial private equity interest over the past five years. Women's health, in particular, has emerged as a priority investment area following years of underinvestment and growing recognition of gender-specific healthcare gaps.

Financial terms of the partnership were not disclosed, though industry sources suggest the deal structure includes both initial capital deployment and committed dry powder for add-on acquisitions. All Seas Capital's typical investment range spans $10 million to $50 million in enterprise value, suggesting Sereni falls within this sweet spot for platform-building opportunities.

"Sereni has built an exceptional foundation in women's wellness with a patient-centric approach that delivers measurable outcomes," said Marcus Johnson, Managing Partner at All Seas Capital. "We see tremendous opportunity to expand their footprint through strategic acquisitions while maintaining the quality and personalized care that differentiates their model."

Founded in 2021, Sereni operates a network of women's health clinics offering integrated services spanning gynecology, hormone therapy, mental health support, and nutritional counseling. The company's model emphasizes longer consultation times, coordinated care teams, and technology-enabled patient engagement—a departure from the rushed, compartmentalized approach common in traditional healthcare delivery.

The platform currently operates five locations across South Florida, serving approximately 12,000 active patients. Revenue has grown at a compound annual rate exceeding 85% over the past three years, driven by both same-clinic expansion and new location openings. Patient retention rates exceed 90%, significantly above industry benchmarks.

Sereni's clinical team includes board-certified physicians, nurse practitioners, licensed therapists, and registered dietitians who collaborate on individualized care plans. The company has invested heavily in proprietary scheduling and electronic health record systems designed specifically for its integrated care model, creating workflow efficiencies that support its longer appointment times without sacrificing profitability.

"Our patients tell us they've been searching for years for a healthcare experience that actually listens to their concerns and treats them as whole people, not just a series of isolated symptoms," said Dr. Maria Castellanos, founder and CEO of Sereni. "This partnership with All Seas gives us the resources to bring this model to more women who desperately need better options."

The women's health services market remains highly fragmented, with thousands of independent practices and small clinic groups serving local markets. This fragmentation creates both service delivery inefficiencies and significant consolidation opportunities for well-capitalized platforms with proven operating models.

All Seas Capital's investment thesis centers on Sereni's ability to serve as an acquisition platform, identifying and integrating complementary practices that can benefit from operational support, technology infrastructure, and back-office services while maintaining clinical independence and local market knowledge.

The firm has identified an initial pipeline of potential acquisition targets including independent gynecology practices, hormone therapy clinics, and mental health counseling groups. Target acquisitions will focus on established practices with strong patient relationships and reputations, but limited access to capital for growth or technology investment.

Typical acquisition structures will likely combine upfront payments with earnouts tied to patient retention and revenue growth metrics, allowing founding physicians to benefit from Sereni's platform advantages while maintaining clinical input and patient relationships during transition periods.

Sereni's expansion strategy prioritizes high-growth Sun Belt markets with favorable demographics and strong healthcare spending patterns. Target cities include Atlanta, Charlotte, Nashville, Austin, and Phoenix—markets with rapidly growing populations of educated, health-conscious women aged 25-55, Sereni's core demographic.

The Sereni investment reflects broader private equity enthusiasm for healthcare services platforms, particularly those targeting specific patient populations or clinical specialties. Healthcare services deals represented approximately 23% of all private equity transactions in 2025, up from 18% in 2020, according to PitchBook data.

Women's health has emerged as a particularly attractive subsector, driven by several converging factors: growing awareness of gender disparities in medical research and treatment, increasing patient willingness to seek specialized care, favorable reimbursement trends for preventive and holistic services, and the rise of value-based care models that reward patient outcomes over service volume.

Recent comparable transactions include Warburg Pincus's investment in Tia, a modern women's health clinic chain, and General Atlantic's backing of Maven Clinic, a virtual care platform focused on women's and family health. These deals have validated the market opportunity and demonstrated strong investor appetite for scalable women's health platforms.

However, healthcare services consolidation also carries distinct risks. Regulatory complexity varies significantly by state, particularly regarding scope of practice, telehealth, and reproductive services. Integration challenges can prove substantial when combining independent practices with different clinical cultures, technology systems, and patient populations. Quality maintenance during rapid growth remains a persistent concern across healthcare roll-ups.

"The key differentiator in healthcare buy-and-builds is maintaining clinical quality and patient satisfaction while achieving operational scale," noted Jennifer Park, healthcare analyst at Leerink Partners. "The successful platforms are those that enhance rather than constrain clinical practice, and that's a much harder balance than most financial buyers initially appreciate."

All Seas Capital's investment team includes several professionals with direct healthcare operating experience, a capability the firm views as essential for value creation in medical services platforms. The firm's portfolio includes two other healthcare services businesses: a behavioral health clinic network and a home health services provider.

This operational orientation distinguishes All Seas from purely financial buyers and positions the firm to support Sereni through the operational complexities of healthcare M&A, including credentialing, payer contracting, regulatory compliance, and clinical integration.

A critical component of Sereni's platform value proposition is its proprietary technology infrastructure, which the company has developed specifically to support its integrated care model. The system combines electronic health records, patient engagement tools, care coordination workflows, and analytics capabilities in a unified platform.

This technology investment provides several competitive advantages as Sereni pursues acquisitions. Acquired practices gain immediate access to modern systems that improve clinical efficiency and patient communication. Centralized data enables population health management and outcome tracking across the entire network. Standardized workflows facilitate best practice sharing while preserving appropriate clinical autonomy.

The platform also supports telehealth capabilities, which have become increasingly important for women's healthcare. Many patients value the convenience and privacy of virtual consultations for sensitive topics including hormone therapy management, mental health support, and nutritional counseling. Sereni's hybrid model combining in-person and virtual care has driven patient acquisition and retention.

All Seas Capital plans to fund continued technology development as part of the partnership, including enhancements to patient self-service capabilities, AI-powered care coordination tools, and advanced analytics for clinical outcomes tracking. These investments will position Sereni to compete effectively against both traditional healthcare systems and venture-backed digital health competitors.

Sereni operates a hybrid reimbursement model that combines traditional insurance billing for covered services with direct-pay options for enhanced access and holistic wellness programs. Approximately 65% of revenue currently comes from insurance reimbursement, with the remainder from membership fees and cash-pay services.

This diversified revenue model provides both scale opportunities through insurance networks and margin protection through direct-pay offerings. It also positions Sereni to adapt to evolving reimbursement trends, including growing insurer interest in preventive care and holistic wellness programs that demonstrate improved patient outcomes and reduced downstream costs.

Sereni competes against several distinct categories of women's health providers, each with different strengths and limitations. Traditional healthcare systems offer comprehensive services and insurance access but often struggle with appointment availability, coordination across specialties, and patient experience. Independent practices provide personalized care but lack technology, capital, and operational sophistication for growth.

Digital-first competitors like Tia, Maven, and Twentyeight Health have attracted significant venture capital and built strong brands, but many remain unprofitable and face challenges with clinical depth and in-person service delivery. Emerging retail health players including CVS and Walgreens are expanding women's health offerings but face skepticism about clinical quality and care continuity.

Sereni's strategy positions the company between these extremes: more technologically sophisticated and operationally scalable than traditional practices, but with deeper clinical capabilities and in-person presence than digital-only competitors. This middle path requires careful execution but may prove optimal for patients seeking both convenience and comprehensive care.

"Women's health is too complex and personal for purely digital solutions, but the traditional system is too broken to meet modern patient expectations," said Dr. Castellanos. "We're building something that combines the best of both worlds—accessible, technology-enabled care delivered by experienced clinicians who have time to truly understand each patient's unique situation."

Several structural market factors support the investment thesis behind women's health platforms like Sereni. The U.S. women's health market exceeded $50 billion in annual spending in 2025, with growth rates consistently outpacing overall healthcare spending. Demographic trends remain favorable, with millennial and Gen Z women demonstrating higher healthcare engagement and willingness to seek specialized care than previous generations.

Policy momentum is also building around women's health investment. The Biden administration's National Strategy on Gender Equity included substantial funding increases for women's health research and service delivery. State-level initiatives have expanded insurance coverage for preventive women's health services, improving reimbursement for exactly the types of comprehensive care Sereni provides.

Consumer awareness of women's health gaps has increased dramatically, driven by social media, advocacy organizations, and media coverage of gender disparities in medical research and treatment. This awareness is translating into patient demand for specialized women's health services and willingness to pay for enhanced access and comprehensive care.

Corporate wellness programs are also expanding coverage for women's health services, recognizing the business impact of unaddressed hormonal, reproductive, and mental health issues on employee productivity and retention. This trend creates additional revenue opportunities for platforms like Sereni through employer partnerships and B2B service contracts.

Sereni and All Seas Capital have developed a detailed integration playbook for acquired practices, emphasizing gradual operational transition while protecting patient relationships and clinical autonomy. The approach prioritizes early wins in back-office efficiency and technology enablement before addressing more sensitive areas like clinical protocols and staffing models.

Acquired practices will retain their existing names and branding during an initial transition period, with gradual evolution toward the Sereni brand as patient awareness and acceptance grows. Founding physicians will maintain clinical leadership roles and participate in network-wide clinical governance, ensuring that integration enhances rather than constrains medical decision-making.

The integration roadmap includes substantial investment in acquired practices, including facility upgrades, technology implementation, staff training, and marketing support. This investment-oriented approach distinguishes Sereni from cost-cutting roll-ups and aligns incentives between the platform and acquired practices around growth and quality metrics.

All Seas Capital will provide dedicated integration support resources including project managers, technology specialists, and payer contracting experts who will work alongside acquired practice leadership during transition periods. This hands-on support accelerates value realization while reducing execution risk.

Success metrics for acquisitions will emphasize patient retention, clinical outcomes, physician satisfaction, and organic growth alongside traditional financial metrics. This balanced scorecard approach reflects both parties' commitment to sustainable growth that maintains Sereni's quality-focused positioning.

Sereni's growth plan envisions completing 15-20 acquisitions over a three-year period, with initial deals expected to close in second quarter 2026. The aggressive timeline reflects both market opportunity and the need to establish market leadership before competition intensifies.

Early acquisitions will focus on markets adjacent to Sereni's existing Florida footprint, leveraging management team familiarity with regional market dynamics and enabling cross-market operational synergies. Subsequent expansion will target priority Sun Belt markets, with 2-3 acquisitions per market to establish meaningful local presence.

Deal sourcing will combine proactive outreach to identified targets, broker relationships in the healthcare M&A market, and inbound interest generated by Sereni's growing market presence and reputation. All Seas Capital's transaction team and network will supplement Sereni's internal development efforts.

The partnership structure includes committed capital for acquisitions as well as organic growth investment, providing flexibility to pursue both inorganic and organic expansion opportunities as they emerge. This dual-track approach reduces execution risk by avoiding over-dependence on M&A pipeline conversion while maintaining aggressive growth targets.